Cian Healthcare Limited

CHCL

INE05BN01019

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:57 02/07/2024 BST			5-day change	1st Jan Change
23.15 ^INR	-2.53%		-5.82%	+35.62%

2023	Cian Healthcare to Supply 13 Pharmaceutical Products for HLL Lifecare	MT
2023	Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

Cian Healthcare Limited Announce Change in Corporate Office

November 23, 2021 at 12:13 pm

Cian Healthcare Limited approved the proposal for change in corporate office of Company from 1st & 2nd Floor, Premdeep Building, Above latur urban Bank Ltd. Lullanagar Chowk Camp Kondhwa Road Pune 411040 MH IN to Office No. 508-511, Sacred World, South Block, 5th Floor, Above Macdonald, Vitthal Rao Shivarkar Road, Wanowrie, Pune 411040 with effect from 23rd November, 2021.

Latest news about Cian Healthcare Limited

Cian Healthcare to Supply 13 Pharmaceutical Products for HLL Lifecare	12-06	MT
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-14	CI
Cian Healthcare to Export Products to Guatemala Via New Deal	11/10/23	MT
Cian Healthcare Limited Enters into Merchant Export Agreement with Tamil Pharma Pvt Ltd	11/10/23	CI
Cian Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	05/09/23	CI
Cian Healthcare Signs Deal to Manufacture Products for Nigerian Pharmaceutical Firm	22/08/23	MT
Cian Healthcare Limited Enters into an Agreement with CHI Pharmaceuticals Limited	22/08/23	CI
Crisil Lowers Rating on Cian Healthcare's Bank Loans to D; Outlook	20/07/23	MT
Crisil Gives B+ Rating to Cian Healthcare's Bank Loans; Outlook Stable	02/03/23	MT
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2022	14/11/22	CI
Cian Healthcare Limited Announces Resignation of Santosh Pimparkar as Wholetime Director	08/10/22	CI
Cian Healthcare Gets Board's Approval to Move Shares to BSE's Main Board	26/09/22	MT
Cian Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2022	05/09/22	CI
Cian Healthcare Limited Appoints Paresh Arun Shah as Additional Director, Date of Appointment Is 25 August, 2022	26/08/22	CI
Cian Healthcare Limited Announces Resignation of Damodarkumar Sharma as Wholetime Director	12/07/22	CI
4,900,000 Equity Shares of Cian Healthcare Limited are subject to a Lock-Up Agreement Ending on 30-MAY-2022.	29/05/22	CI
Cian Healthcare Limited Announces Resignation of Mohammad Raees Sheikh as Non-Executive Independent Director	31/03/22	CI
Cian Healthcare Limited Announces Resignation of Shikha Rai as Independent Non-Executive Director	25/02/22	CI
Cian Healthcare Limited Announce Change in Corporate Office	23/11/21	CI
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2021	19/11/21	CI
Cian Healthcare Widens Consolidated Net Loss in Fiscal H1	18/11/21	MT
Cian Healthcare Limited Announces Board Changes	13/10/21	CI
Cian Healthcare Limited announced a financing transaction	11/10/21	CI
Cian Healthcare Limited Announces the Resignation of Dhiraj Shantilal Ostwal as Non-Executive Additional Director of the Company	04/10/21	CI
Cian Healthcare Limited Reports Standalone Earnings Results for the Year Ended March 31, 2021	07/09/21	CI

Chart Cian Healthcare Limited

Duration

Period

More charts

Company Profile

Cian Healthcare Limited is an India-based company, which is engaged in the manufacturing and marketing of pharmaceutical products. The Company is engaged in manufacturing of multiple lines-tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets, cosmetics. The Company operates in five sectors, such as Export, Government Supplies, Merchant Export, Own Brand Franchise Business and Third Party/ Contract manufacturing. Its portfolio comprises gynecology, haematinic, cardio- diabetic, orthopedic, pediatric, derma-cosmetic, and antibiotic, CNS, vitamin and nutrient products. The Company also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, Sri Lanka, Myanmar and also enhances its production capacity by installing additional machinery for manufacturing a variety of products. It is also engaged in the business of manufacturing cosmetic products. The Company's subsidiary includes Dr. Smith Biotech Private Limited.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CIAN HEALTHCARE LIMITED	+35.62%	7.11M
ELI LILLY AND COMPANY	+55.40%	823B
NOVO NORDISK A/S	+42.31%	641B
JOHNSON & JOHNSON	-6.95%	352B
MERCK & CO., INC.	+17.21%	324B
ABBVIE INC.	+7.52%	301B
ASTRAZENECA PLC	+14.02%	241B
ROCHE HOLDING AG	+1.64%	223B
NOVARTIS AG	+13.66%	218B
AMGEN INC.	+8.31%	167B